317 related articles for article (PubMed ID: 26920949)
21. Effects of Acotiamide on the Esophageal Motility Function in Patients with Esophageal Motility Disorders: A Pilot Study.
Muta K; Ihara E; Fukaura K; Tsuchida O; Ochiai T; Nakamura K
Digestion; 2016; 94(1):9-16. PubMed ID: 27326454
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of acotiamide in combination with esomeprazole for functional dyspepsia refractory to proton-pump inhibitor monotherapy.
Mayanagi S; Kishino M; Kitagawa Y; Sunamura M
Tohoku J Exp Med; 2014 Nov; 234(3):237-40. PubMed ID: 25382232
[TBL] [Abstract][Full Text] [Related]
23. Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria.
Vanheel H; Carbone F; Valvekens L; Simren M; Tornblom H; Vanuytsel T; Van Oudenhove L; Tack J
Am J Gastroenterol; 2017 Jan; 112(1):132-140. PubMed ID: 27958284
[TBL] [Abstract][Full Text] [Related]
24. Acotiamide affects antral motility, but has no effect on fundic motility, gastric emptying or symptom perception in healthy participants.
Masuy I; Tack J; Verbeke K; Carbone F
Neurogastroenterol Motil; 2019 Apr; 31(4):e13540. PubMed ID: 30663175
[TBL] [Abstract][Full Text] [Related]
25. Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap.
Carbone F; Holvoet L; Tack J
Neurogastroenterol Motil; 2015 Aug; 27(8):1069-74. PubMed ID: 26220647
[TBL] [Abstract][Full Text] [Related]
26. Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia.
Lee KJ; Cha DY; Cheon SJ; Yeo M; Cho SW
Digestion; 2009; 80(1):58-63. PubMed ID: 19494492
[TBL] [Abstract][Full Text] [Related]
27. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia.
Matsueda K; Hongo M; Tack J; Saito Y; Kato H
Gut; 2012 Jun; 61(6):821-8. PubMed ID: 22157329
[TBL] [Abstract][Full Text] [Related]
28. A long-term study of acotiamide in patients with functional dyspepsia: results from an open-label phase III trial in Japan on efficacy, safety and pattern of administration.
Matsueda K; Hongo M; Ushijima S; Akiho H
Digestion; 2011; 84(4):261-8. PubMed ID: 21934307
[TBL] [Abstract][Full Text] [Related]
29. Adherence to an acotiamide therapeutic regimen improves long-term outcomes in patients with functional dyspepsia.
Shinozaki S; Osawa H; Sakamoto H; Hayashi Y; Miura Y; Lefor AK; Yamamoto H
J Gastrointestin Liver Dis; 2017 Dec; 26(4):345-350. PubMed ID: 29253047
[TBL] [Abstract][Full Text] [Related]
30. Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients.
Shinomiya T; Fukunaga M; Akamizu T; Irako T; Yokode M; Kangawa K; Nakai Y; Nakai Y
Scand J Gastroenterol; 2005 Jun; 40(6):648-53. PubMed ID: 16036524
[TBL] [Abstract][Full Text] [Related]
31. Impact of sleep disorders in Japanese patients with functional dyspepsia (FD): nizatidine improves clinical symptoms, gastric emptying and sleep disorders in FD patients.
Futagami S; Yamawaki H; Izumi N; Shimpuku M; Kodaka Y; Wakabayashi T; Nagoya H; Shindo T; Kawagoe T; Gudis K; Itoh T; Sakamoto C
J Gastroenterol Hepatol; 2013 Aug; 28(8):1314-20. PubMed ID: 23611167
[TBL] [Abstract][Full Text] [Related]
32. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin.
Arai M; Matsumura T; Tsuchiya N; Sadakane C; Inami R; Suzuki T; Yoshikawa M; Imazeki F; Yokosuka O
Hepatogastroenterology; 2012; 59(113):62-6. PubMed ID: 22260823
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of acotiamide for the treatment of functional dyspepsia: systematic review and meta-analysis.
Xiao G; Xie X; Fan J; Deng J; Tan S; Zhu Y; Guo Q; Wan C
ScientificWorldJournal; 2014; 2014():541950. PubMed ID: 25197703
[TBL] [Abstract][Full Text] [Related]
34. Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with functional dyspepsia.
Takamori K; Mizuta Y; Takeshima F; Akazawa Y; Isomoto H; Ohnita K; Ohba K; Omagari K; Shikuwa S; Kohno S
J Clin Gastroenterol; 2007; 41(5):477-83. PubMed ID: 17450030
[TBL] [Abstract][Full Text] [Related]
35. Effects of acotiamide on functional dyspepsia patients with heartburn who failed proton pump inhibitor treatment in Japanese patients: A randomized, double-blind, placebo-controlled crossover study.
Funaki Y; Ogasawara N; Kawamura Y; Yoshimine T; Tamura Y; Izawa S; Ebi M; Sasaki M; Kasugai K
Neurogastroenterol Motil; 2020 Feb; 32(2):e13749. PubMed ID: 31612597
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of Acotiamide Versus Mosapride in Patients With Functional Dyspepsia Associated With Meal-Induced Postprandial Distress Syndrome: A Phase III Randomized Clinical Trial.
Sinha S; Chary S; Thakur P; Talluri L; Reddy M; K GS; Mohan JM; Jain P; Naik S; C Reddy SV
Cureus; 2021 Sep; 13(9):e18109. PubMed ID: 34692320
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
[TBL] [Abstract][Full Text] [Related]
38. Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia--a multicenter, double-blind, randomized, placebo-controlled study.
Suzuki H; Matsuzaki J; Fukushima Y; Suzaki F; Kasugai K; Nishizawa T; Naito Y; Hayakawa T; Kamiya T; Andoh T; Yoshida H; Tokura Y; Nagata H; Kobayakawa M; Mori M; Kato K; Hosoda H; Takebayashi T; Miura S; Uemura N; Joh T; Hibi T; Tack J;
Neurogastroenterol Motil; 2014 Jul; 26(7):950-61. PubMed ID: 24766295
[TBL] [Abstract][Full Text] [Related]
39. The latent structure of the functional dyspepsia symptom complex: a taxometric analysis.
Van Oudenhove L; Jasper F; Walentynowicz M; Witthöft M; Van den Bergh O; Tack J
Neurogastroenterol Motil; 2016 Jul; 28(7):985-93. PubMed ID: 27339217
[TBL] [Abstract][Full Text] [Related]
40. Current and emerging therapeutic options for the management of functional dyspepsia.
Vandenberghe A; Schol J; Van den Houte K; Masuy I; Carbone F; Tack J
Expert Opin Pharmacother; 2020 Feb; 21(3):365-376. PubMed ID: 31899982
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
